Dr Dominic Leonard Oteri, MD in Drexel Hill, PA - Medicare Family Medicine

Dr Dominic Leonard Oteri, MD is a medicare enrolled "Family Medicine" physician in Drexel Hill, Pennsylvania. His current practice location is 2100 Keystone Ave, Drexel Hill, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (610) 394-9414.

Dr Dominic Leonard Oteri is licensed to practice in Pennsylvania (license number MD055989L) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1326269945.

Contact Information

	Dr Dominic Leonard Oteri, MD
	2100 Keystone Ave, Drexel Hill, PA 19026
	(610) 394-9414
	Not Available

Physician's Profile

Full Name	Dr Dominic Leonard Oteri
Gender	Male
Speciality	Family Medicine
Location	2100 Keystone Ave, Drexel Hill, Pennsylvania
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1326269945
Provider Enumeration Date: 05/01/2007
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 8628014172
Enrollment ID: I20050707000308

Medical Identifiers

Medical identifiers for Dr Dominic Leonard Oteri such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1326269945	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	MD055989L (Pennsylvania)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Dominic Leonard Oteri allows following entities to bill medicare on his behalf.

Entity Name	American Current Care Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1477734861 PECOS PAC ID: 9739260019 Enrollment ID: O20080618000325

News Archive

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration approved the new drug application for Tresiba (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba provides a long duration of action beyond 42 hours.

Phase I clinical trial of DFMO initiated to treat children with neuroblastoma

A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma.

Washington's insurance exchange is winning, too; N.Y. and Calif. see strong Obamacare enrollment numbers

More than 33 percent of eligible Washington residents have signed up for care on the state's health law online insurance exchange. In New York and California, exchanges see big sign-up numbers. Finally, lawmakers in Florida and Virginia ready plans for insurance exchanges that aren't part of the health law.

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today that the European Commission has granted Orphan Medicinal Product Designation to its lead drug candidate PRM-151 for use in the prevention of scarring post glaucoma filtration surgery.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dominic Leonard Oteri is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Dominic Leonard Oteri, MD 2100 Keystone Ave, Drexel Hill, PA 19026 Ph: (610) 394-9414	Dr Dominic Leonard Oteri, MD 2100 Keystone Ave, Drexel Hill, PA 19026 Ph: (610) 394-9414

News Archive

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Phase I clinical trial of DFMO initiated to treat children with neuroblastoma

Washington's insurance exchange is winning, too; N.Y. and Calif. see strong Obamacare enrollment numbers

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Family Medicine Doctors in Drexel Hill, PA

Dr. Anita Ott, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5030 State Road, Suite 2-400, Drexel Hill, PA 19026 Phone: 610-394-1365 Fax: 610-394-1368
Dr. Robert C Madonna Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2504 Garrett Rd, Drexel Hill, PA 19026 Phone: 484-466-3007 Fax: 474-466-3042
Dr. Dennis W Kropp, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3909 State Rd, Drexel Hill, PA 19026 Phone: 610-853-2544 Fax: 610-853-1223
Margaret Lane, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6-4 Wilde Ave, Drexel Hill, PA 19026 Phone: 570-223-4860
Mark Hanh Van Dang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Keystone Ave, Suite 506, Drexel Hill, PA 19026 Phone: 610-394-9414
Dr. Samuel Louis Krakow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3836 Brunswick Ave, Drexel Hill, PA 19026 Phone: 610-547-9081

Dr Dominic Leonard Oteri, MD - Medicare Family Medicine in Drexel Hill, PA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Phase I clinical trial of DFMO initiated to treat children with neuroblastoma

Washington's insurance exchange is winning, too; N.Y. and Calif. see strong Obamacare enrollment numbers

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Phase I clinical trial of DFMO initiated to treat children with neuroblastoma

Washington's insurance exchange is winning, too; N.Y. and Calif. see strong Obamacare enrollment numbers

Promedior granted European Orphan Medicinal Product Designation for PRM-151

Family Medicine Doctors in Drexel Hill, PA